Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation
Authors
Keywords
-
Journal
PEDIATRIC TRANSPLANTATION
Volume 15, Issue 1, Pages 37-46
Publisher
Wiley
Online
2010-10-08
DOI
10.1111/j.1399-3046.2010.01405.x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cinacalcet Decreases Bone Formation Rate in Hypercalcemic Hyperparathyroidism after Kidney Transplantation
- (2010) Kyra A. Borchhardt et al. AMERICAN JOURNAL OF NEPHROLOGY
- The Influence of Glomerular Filtration Rate and Age on Fibroblast Growth Factor 23 Serum Levels in Pediatric Chronic Kidney Disease
- (2010) Justine Bacchetta et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet
- (2010) Rita Guerra et al. JOURNAL OF NEPHROLOGY
- Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease
- (2010) M. Wolf JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease
- (2010) Michael van Husen et al. KIDNEY INTERNATIONAL
- Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease
- (2010) Hisashi Hasegawa et al. KIDNEY INTERNATIONAL
- Rapamycin-induced phosphaturia
- (2010) D. S. Kempe et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Pediatric Kidney Transplantation
- (2010) Ron Shapiro et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Two decades of pediatric kidney transplantation in a multi-ethnic cohort
- (2010) Samina Muneeruddin et al. PEDIATRIC TRANSPLANTATION
- Renal Allograft Calcification – Prevalence and Etiology in Pediatric Patients
- (2009) Sandra Habbig et al. AMERICAN JOURNAL OF NEPHROLOGY
- Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
- (2009) Heng Jung Hsu et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Localization, Etiology and Impact of Calcium Phosphate Deposits in Renal Allografts
- (2009) P. Evenepoel et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
- (2009) R. B. Oliveira et al. Clinical Journal of the American Society of Nephrology
- Therapeutic Effects of Anti-FGF23 Antibodies in Hypophosphatemic Rickets/Osteomalacia*
- (2009) Yukiko Aono et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Circulating Fibroblast Growth Factor 23 in Patients with End-Stage Renal Disease Treated by Peritoneal Dialysis Is Intact and Biologically Active
- (2009) Takashi Shimada et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Relationship between circulating FGF23 and total body atherosclerosis in the community
- (2009) Majd A. I. Mirza et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study
- (2009) J. H. Ix et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Subclinical atherosclerosis and related risk factors in renal transplant recipients
- (2009) Mitra Basiratnia et al. PEDIATRIC NEPHROLOGY
- High prevalence of the metabolic syndrome and associated left ventricular hypertrophy in pediatric renal transplant recipients
- (2009) Amy C. Wilson et al. PEDIATRIC TRANSPLANTATION
- High Prevalence of Vitamin D Deficiency in African American Kidney Transplant Recipients
- (2009) Shreyank S. Tripathi et al. TRANSPLANTATION
- Treatment With Cinacalcet in 29 Kidney Transplant Patients With Persistent Hyperparathyroidism
- (2009) V. López et al. TRANSPLANTATION PROCEEDINGS
- Vitamin D Deficiency in Kidney Transplant Recipients: Risk Factors and Effects of Vitamin D3 Supplements
- (2009) R. Marcén et al. TRANSPLANTATION PROCEEDINGS
- Phosphatemic Effect of Cinacalcet in Kidney Transplant Recipients With Persistent Hyperparathyroidism
- (2008) Andreas L. Serra et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Association of Activated Vitamin D Treatment and Mortality in Chronic Kidney Disease
- (2008) Csaba P. Kovesdy ARCHIVES OF INTERNAL MEDICINE
- Calcimimetics as an Adjuvant Treatment for Familial Hypophosphatemic Rickets
- (2008) U. S. Alon et al. Clinical Journal of the American Society of Nephrology
- Recovery of Hyperphosphatoninism and Renal Phosphorus Wasting One Year after Successful Renal Transplantation
- (2008) P. Evenepoel et al. Clinical Journal of the American Society of Nephrology
- Anti-FGF23 Neutralizing Antibodies Show the Physiological Role and Structural Features of FGF23
- (2008) Yuji Yamazaki et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Relationship between Plasma Fibroblast Growth Factor-23 Concentration and Bone Mineralization in Children with Renal Failure on Peritoneal Dialysis
- (2008) Katherine Wesseling-Perry et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A rat model of chronic kidney disease-mineral bone disorder
- (2008) Sharon M. Moe et al. KIDNEY INTERNATIONAL
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term outcome of chronic dialysis in children
- (2008) Rukshana Shroff et al. PEDIATRIC NEPHROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started